 |
21 Diseases |  |
0 Trials |
|
0 Trials |  |
34 News |  |
- | AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Trial completion, Trial completion date, Trial primary completion date: Healthy Patients & Effect of Antibiotics (clinicaltrials.gov) - Nov 10, 2022
P=N/A, N=20, Completed, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed | Trial completion date: Dec 2022 --> Aug 2022 | Trial primary completion date: Dec 2022 --> Aug 2022
- ||| AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Azasite is the "hot potato" again. Will Thea keep it? My latest: https://t.co/ycvUUA3XS4 @n8radcliffe gets a question! @preeyakgupta @LizYeu @djmjspin @Dryeyemaster @drfishman (Twitter) - Feb 23, 2022
- | AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Trial completion date, Trial primary completion date: Healthy Patients & Effect of Antibiotics (clinicaltrials.gov) - Jan 28, 2022
P=N/A, N=20, Active, not recruiting, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed | Trial completion date: Dec 2022 --> Aug 2022 | Trial primary completion date: Dec 2022 --> Aug 2022 Trial completion date: Dec 2021 --> Dec 2022 | Trial primary completion date: Dec 2021 --> Dec 2022
- | AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Trial completion date, Trial primary completion date: Healthy Patients & Effect of Antibiotics (clinicaltrials.gov) - Apr 23, 2021
P=N/A, N=20, Active, not recruiting, Sponsor: Washington University School of Medicine
Trial completion date: Dec 2021 --> Dec 2022 | Trial primary completion date: Dec 2021 --> Dec 2022 Trial completion date: Dec 2020 --> Dec 2021 | Trial primary completion date: Dec 2020 --> Dec 2021
- ||| AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Nice article. I will give a solid retweet to anyone who can come up with a picture of the green Azasite umbrellas that Merck was giving away like mad during the AAO launch in ?2007? (Twitter) - Jul 18, 2020
- || AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Just gonna leave this tidbit here so that I don't forget to share it Monday morning. The company that owns #Azasite files for bankruptcy. https://t.co/bOnfkpOZ2z The abuse continues. Maybe Azasite is the Bermuda Triangle of drugs: each company that owns it disappears. (Twitter) - Jul 17, 2020
- | AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Trial completion date, Trial primary completion date: Healthy Patients & Effect of Antibiotics (clinicaltrials.gov) - Apr 6, 2020
P=N/A, N=20, Active, not recruiting, Sponsor: Washington University School of Medicine
Trial completion date: Dec 2020 --> Dec 2021 | Trial primary completion date: Dec 2020 --> Dec 2021 Trial completion date: Dec 2019 --> Dec 2020 | Trial primary completion date: Dec 2019 --> Dec 2020
- | Review, Journal: Drugs for common eye disorders. (Pubmed Central) - Dec 22, 2019
Trial completion date: Dec 2019 --> Dec 2020 | Trial primary completion date: Dec 2019 --> Dec 2020 No abstract available
- | AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Trial completion date, Trial primary completion date: Healthy Patients & Effect of Antibiotics (clinicaltrials.gov) - Jul 16, 2019
P=N/A, N=20, Active, not recruiting, Sponsor: Washington University School of Medicine
No abstract available Trial completion date: Sep 2019 --> Dec 2019 | Trial primary completion date: Jun 2019 --> Dec 2019
- | AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Trial completion date: Healthy Patients & Effect of Antibiotics (clinicaltrials.gov) - May 28, 2019
P=N/A, N=20, Active, not recruiting, Sponsor: Washington University School of Medicine
Trial completion date: Sep 2019 --> Dec 2019 | Trial primary completion date: Jun 2019 --> Dec 2019 Trial completion date: Jun 2019 --> Sep 2019
- | AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Trial completion date, Trial primary completion date: Healthy Patients & Effect of Antibiotics (clinicaltrials.gov) - Jul 24, 2018
P=N/A, N=20, Active, not recruiting, Sponsor: Washington University School of Medicine
Trial completion date: Jun 2019 --> Sep 2019 Trial completion date: Jun 2018 --> Jun 2019 | Trial primary completion date: Jun 2018 --> Jun 2019
- | AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Trial primary completion date: Healthy Patients & Effect of Antibiotics (clinicaltrials.gov) - Jan 29, 2018
P=N/A, N=20, Active, not recruiting, Sponsor: Washington University School of Medicine
Trial completion date: Jun 2018 --> Jun 2019 | Trial primary completion date: Jun 2018 --> Jun 2019 Trial primary completion date: Dec 2017 --> Jun 2018
- | AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Trial completion, Enrollment change: Lipids of the Human Tear Film and Their Effect on Tear Stability (clinicaltrials.gov) - Dec 22, 2017
P4, N=31, Completed, Sponsor: University of Louisville
Trial primary completion date: Dec 2017 --> Jun 2018 Recruiting --> Completed | N=400 --> 31
- | azithromycin / Generic mfg.
New P1 trial: Local Pharmacokinetics of Azithromycin Eye Drops in Healthy Volunteers (clinicaltrials.gov) - Jul 31, 2017
P1, N=56, Recruiting, Sponsor: Beijing Tongren Hospital
- | AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Enrollment closed: Healthy Patients & Effect of Antibiotics (clinicaltrials.gov) - Apr 30, 2017
P=N/A, N=20, Active, not recruiting, Sponsor: Washington University School of Medicine
Recruiting --> Completed | N=400 --> 31 Recruiting --> Active, not recruiting
- | AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
New trial: Healthy Patients & Effect of Antibiotics (clinicaltrials.gov) - Mar 31, 2017
P=N/A, N=20, Recruiting, Sponsor: Washington University School of Medicine
- ||||||| AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Trial completion: Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003) (clinicaltrials.gov) - Feb 6, 2017
P3, N=685, Completed, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Active, not recruiting Recruiting --> Completed
- ||||||| AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Trial completion: Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004) (clinicaltrials.gov) - Feb 6, 2017
P3, N=743, Completed, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Completed Recruiting --> Completed
- AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Enrollment change, Trial withdrawal: Study to Determine the Effect of Azasite on Corneal Surface Irregularity (clinicaltrials.gov) - Sep 28, 2016
P2, N=0, Withdrawn, Sponsor: Philadelphia Eye Associates
Recruiting --> Completed N=30 --> 0 | Terminated --> Withdrawn
- montelukast / Generic mfg., azithromycin / Generic mfg.
Trial completion, Enrollment change: FAM for BOS: Targeted Therapy of Bronchiolitis Obliterans Syndrome (clinicaltrials.gov) - Jan 21, 2016
P2, N=5, Completed, Sponsor: Fred Hutchinson Cancer Research Center
N=30 --> 0 | Terminated --> Withdrawn Active, not recruiting --> Completed | N=42 --> 5
- montelukast / Generic mfg., azithromycin / Generic mfg.
Enrollment closed: FAM for BOS: Targeted Therapy of Bronchiolitis Obliterans Syndrome (clinicaltrials.gov) - Jul 30, 2014
P2, N=42, Active, not recruiting, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed | N=42 --> 5 Recruiting --> Active, not recruiting
- AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Trial termination: Study to Determine the Effect of Azasite on Corneal Surface Irregularity (clinicaltrials.gov) - Jul 17, 2014
P2, N=30, Terminated, Sponsor: Philadelphia Eye Associates
Recruiting --> Active, not recruiting Recruiting --> Terminated; Lack of enrollment
- montelukast / Generic mfg., azithromycin / Generic mfg.
Trial primary completion date: FAM for BOS: Targeted Therapy of Bronchiolitis Obliterans Syndrome (clinicaltrials.gov) - Jul 1, 2014
P2, N=42, Recruiting, Sponsor: Fred Hutchinson Cancer Research Center
Recruiting --> Terminated; Lack of enrollment Trial primary completion date: May 2014 --> Nov 2014
- AzaSite Plus (0.1% azithromycin/0.1% dexamethasone) / Sun Pharma, AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Enrollment change: Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis (clinicaltrials.gov) - Mar 2, 2014
P3, N=0, Withdrawn, Sponsor: InSite Vision
Trial primary completion date: May 2014 --> Nov 2014 N=399 --> 0
- AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Enrollment open: Study to Determine the Effect of Azasite on Corneal Surface Irregularity (clinicaltrials.gov) - Dec 3, 2013
P2, N=30, Recruiting, Sponsor: Philadelphia Eye Associates
N=399 --> 0 Not yet recruiting --> Recruiting
- ||||||| AzaSite Plus (0.1% azithromycin/0.1% dexamethasone) / Sun Pharma, AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Trial completion: Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis (clinicaltrials.gov) - Jun 10, 2013
P3, N=917, Completed, Sponsor: InSite Vision
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
New P2 trial: Study to Determine the Effect of Azasite on Corneal Surface Irregularity (clinicaltrials.gov) - Feb 20, 2013
P2, N=30, Recruiting, Sponsor: Philadelphia Eye Associates
- AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Trial termination: Efficacy of Over the Counter (OTC) Povidone-Ioldine 5% for Treatment of Acute or Chronic Blepharitis (clinicaltrials.gov) - Dec 10, 2012
P=N/A, N=0, Terminated, Sponsor: Southern California Institute for Research and Education
Active, not recruiting --> Completed Recruiting --> Terminated; research staffs unable to continue.